YGZ-331
YGZ-331 is a sedative with a calming effect. YGZ-331 is a derivative of the adenosine nucleoside NGBA, which can increase GABA levels. YGZ-331 exerts a sedative-hypnotic effect by activating A1R and A2aR, and inhibiting CaMKII phosphorylation (pCaMKII) levels. YGZ-331 can reduce the spontaneous motor activity of mice[1].
Product Specifications
CAS Number
1350113-04-0
UNSPSC
12352005
Target
Adenosine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ygz-331.html
Smiles
OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C=NC3=C2N=CN=C3N[C@H](C4=CC=CC=C4)CC)O1
Molecular Formula
C19H23N5O4
Molecular Weight
385.42
References & Citations
[1]Tang B, et al. The mechanism study of YZG-331 on sedative and hypnotic effects[J]. Behavioural Brain Research, 2022, 428: 113885.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2047), CF488A conjugate, 0.1mg/mL
